Third party data processing

To improve our offer, we have information about user behavior by third parties processed.
Here we offer you the opportunity to individually agree to each individual data processing by third parties.

You can adjust these settings at any time in our cookie settings.

Essential cookies

Cookies, which are necessary for the proper operation of our shop.


Google Analytics

Analyzes website usage to deliver custom content.
Performs analytics to optimize website functionality..

Cookie lifetime: 2 years

Google Analytics eCommerce

Conversion tracking with the Google Analytics eCommerce extension.

Type of storage

May we save your settings permanently in the form of a cookie in your browser?
Otherwise, the settings will be lost when you close the browser window.

Cookie settings
AliveCor KardiaMobile 6L - mobile 6-lead ECG heart monitor
Track your heart health in less than 30 seconds with the clinical tested telemdicine system KardiaMobile 6L from Alivecor. The ECG heart monitor with extendend 6-channel measurement warns you in time of atrial fibrillation, bradycardia and tachycardia, in order to detect and prevent heart diseases at an early stage. Receive medically validated measurements conveniently on your smartphone and share your data directly with your doctor. (Set available). Now available for your doctor office with KardiaPro.

KardiaMobile 6L can now be used by healthcare professionals to monitor QT duration in COVID-19 patients
  • Item number: 1145
  • Category: SALE
  • Manufacturer: AliveCor
  • Ships within: 1 - 2 business days

€ 195,00

including 19% VAT , free shipping

Old price: € 229,00


Recommend Product:

{tab Product description}

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

KardiaMobile 6L – the worlds only six-lead personal ECG – is now allowed for use in the measurement of a patients QTc and detection of potentially dangerous QT prolongation. A prolonged QTc can lead to a potentially fatal side effect, called drug-induced sudden cardiac death (DI-SCD), associated with the use of several medicines now being used in the treatment of the Coronavirus.

This has been certified by the FDA for the US, approval in other Markets is currently pending. More information here.

Important information for Covid-19 risk groups and patients:

New FDA guidelines allow the use of KardiaMobile 6L for measuring QTc in COVID-19 patients

At the beginning of this week (week 14/2020) an important milestone was reached when the FDA allowed the use of KardiaMobile 6L to measure QTc intervals in COVID19 patients.

Many drugs currently under discussion for the treatment of COVID19 tend to cause severe ventricular tachycardia due to QT prolongation. It is therefore important to monitor the ECG of these patients for changes. To avoid misunderstandings, we hereby inform you that this is not an automatic function. Your doctor would record the 6-channel ECG and then manually measure the QT time from a printout.

The English press release that describes this in more detail can be found here:

New FDA Guidance allows use of KardiaMobile 6l to measure QT in Covid-19 patients

In addition, there was a publication written by the Mayo Clinic, which contains instructions for the handling of COVID19 patients to reduce the risk of sudden death. They immediately took up the new FDA guidance on KardiaMobile 6L, and this is already included as a recommendation in the paper!

Here the link to the Mayo press release in English and also an interesting video with Dr. Ackerman describing the problem:


The complete publication by Mayo highlights the use of KardiaMobile 6L.

Please note the last 2 pages, which give clear instructions in the form of a flow chart, but also in the operating instructions for KardiaMobile 6L:

Mayoclinic Proceedings

You are welcome to download this publication directly from our download area as a pdf file.

{tab Function}

The KardiaMobile 6L - Information for physicians:

The KardiaMobile 6L is the first and only FDA-cleared and CE marked (Medical Device) six-lead (limb lead) personal ECG for professional and casual users. The six leads offer an improved view of ECG waves (P wave, QRS complex, T wave) compared to a single-lead device.

AliveCor Kardia device allows better discrimination of arrhythmias like bradyarrhythmias, tachyarrhythmias, irregular rhythms (Atrial fibrillation versus sinus rhythm with ectopic beats (PACs)), Chamber hypertrophy and enlargement and Premature ventricular contractions (PVCs).

Thanks to the measurement with six leads, these arrhythmias can be detected and localized much more reliably. Provide your patients with a mobile ECG device to take measurements in critical situations outside your practice. ECG data is stored and can easily be made available via email. The physician can thus decide easily and quickly whether and in what form there is a need for action. CARDIOGONIOMETRY (CGM) is offered in some medical practices. This is a new cardiac diagnostic procedure that can also be used to detect hidden and older infarcts. This is a method for recording the electrical activity of the heart, which enables a spatial representation of the heart currents (3D ECG). In many cases, this allows further information about circulatory disorders in the heart to be displayed.

Please refer to the detailed manual for further information.

Do not hesitate to contact us if you have any questions about the clinical use of the Alivecor Kardia mobile ECG device, discounts for hospital orders or a specific application!

KardiaMobile 6L in use with hands

Important note

The Alivecor KardiaMobile 6L ECG uses a CR2016 battery.

{tab Kardia ECG App}

KardiaMobile 6L with carry pod

New Release of Kardia App available now – New Features for Basic and Premium users!

Extended diagnostic capabilities

  • Bradycardia / Tachycardia: added to the instant ECG analysis (as part of BASIC offering). We are adding additional diagnostic capabilities to KardiaMobile to detect bradycardia and tachycardia symptoms. Many of the ECG recordings currently shown as unclassified will in future show as Bradycardia (40-50 BPM) or Tachycardia (>100 BPM)

Changes to the subscription model:

  • BASIC: Allows local storage of ECGs in the Kardia App (History) Not being able to store ECGs in the app was one of the main features requested by customers. Adding storage capability will contribute significantly to the user experience. Many physicians use our devices to check patients ECGs. Some of them raised data privacy concerns if those ECGs get stored on their (personal) smartphone. Therefore, we implemented a switch, that allows to disable ECG storage in the ECG settings if a customer wishes to do so.

These changes will be available to you with the next update of the app. Please note that the Kardia Band will still require a Premium subscription for use.

{tab Features}

KardiaMobile 6L - Alivecor heart monitor in horizontal view

ECG Charakteristics

  • Six Lead ECG
  • 10 mV peak-to-peak input dynamic range
  • 30 second to 5 minute recording duration
  • 300 samples per second sampling rate
  • 14 bit Resolution


  • 3.5 x 1.18 x 0.27 inches (9x3x0,7cm)
  • Three 1.18 x 1.18 inches (3x3cm) stainless steel electrodes
  • Weight: 24g

Connectivity and battery

  • Bluetooth Low Energy technology
  • 1m wireless range
  • 3V CR2016 coin cell battery (included)
  • 200 hours operational time, 12 months typical use

Apple Compatibility:

iPhone XR (iOS 12.3), iPhone XS (iOS 12.3), iPhone XS Max (iOS 12.3), iPhone X (iOS 12.3), iPhone 8 Plus (iOS 12.3), iPhone 8 (iOS 12.3), iPhone 7 Plus (iOS 12.3), iPhone 7 (iOS 12.3), iPhone 6s Plus (iOS 12.3), iPhone 6s (iOS 12.3), iPhone 6 Plus (iOS 12.3), iPhone 6 (iOS 12.3), iPhone SE (iOS 12.3), iPhone 5s (iOS 12.3), iPad Pro 12" (2nd Gen) (iOS 12.3), iPad Pro 10.5" (2nd Gen) (iOS 12.3), iPad Pro 12" (iOS 12.3), iPad Pro 9" (iOS 12.3), iPad 9.7" (2017) (iOS 12.3), iPad Mini 4 (iOS 12.3), iPad Mini 3 (iOS 12.3), iPad Mini 2 (iOS 12.3)

KardiaMobile 6L ECG device with clip for iPhone

Android Compatibility:

Google Pixel 3a (Android 9.0.0), Google Pixel 3a XL (Android 9.0.0), Google Pixel 3 (Android 9.0.0), Google Pixel 3 XL (Android 9.0.0), Google Pixel 2 (Android 9.0.0), Google Pixel 2 XL (Android 9.0.0), Google Pixel (Android 9.0.0), Google Pixel XL (Android 9.0.0), Huawei Mate 10 (Android 8.0.0), LG Nexus 5 (Android 6.0.1), Motorola Moto G Gen 2 (Android 6.0), Samsung Galaxy S10+ (Android 9.0.0), Samsung Galaxy S10 (Android 9.0.0), Samsung Galaxy S9+ (Android 9.0.0), Samsung Galaxy S9 (Android 8.0.0), Samsung Galaxy S8+ (Android 8.0.0), Samsung Galaxy S8 (Android 7.0.0), Samsung Galaxy S7 (Android 8.0.0), Samsung Galaxy S6 (Android 7.0.0), Samsung Galaxy S5 (Android 6.0.1), Samsung Note 9 (Android 8.1.0), Samsung Note 8 (Android 8.0.0), Samsung Note 5 (Android 7.0.0)

{tab FAQ}

How do I cancel my Kardia App?

  • In the Kardia app, please click on the icon in the upper right corner of the Home screen
  • In the middle right pane go to Manage Membership
  • Tap on Cancel Membership and confirm with Yes in the next step
  • Premium membership will be canceled and monthly / annual fees will no longer be charged

Do you have any questions?

contact link


Target Groups: Advanced Users Physicians Hospital usages Therapist Professional Beginner
Operating System: Android iOS
Applications: Biofeedback Fitness Research Gift Health Heart Rate Telehealth Therapy
Product features: ECG Sensor Multichannel sensor
Product Type: Wearable
Shipping weight:0,30 Kg
Product weight: 0,30 Kg


Kardia Länder-Zulasssung ab März 2020_EN

Kardia Mobile 6L Manual_DE

Kardia Mobile 6L Manual_EN

Kardia App Manual_EN

Kardia App Manual_DE

Kardia Mobile 6L Manual_FR

Kardia Mobile 6L Manual_IT

Kardia Mobile 6L Manual_ES

Kardia App Manual_FR

Kardia App Manual_IT

Kardia App Manual_ES

Compatibility list Kardia Mobile and_6L April 2020